Annual CFF:
-$565.00K-$281.90M(-100.20%)Summary
- As of today, EVH annual cash from financing is -$565.00 thousand, with the most recent change of -$281.90 million (-100.20%) on December 31, 2024.
- During the last 3 years, EVH annual cash from financing has risen by +$28.98 million (+98.09%).
- EVH annual cash from financing is now -100.20% below its all-time high of $281.34 million, reached on December 31, 2023.
Performance
EVH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
-$41.81M-$32.89M(-368.41%)Summary
- As of today, EVH quarterly cash from financing is -$41.81 million, with the most recent change of -$32.89 million (-368.41%) on September 30, 2025.
- Over the past year, EVH quarterly cash from financing has dropped by -$32.81 million (-364.20%).
- EVH quarterly cash from financing is now -111.01% below its all-time high of $379.73 million, reached on March 31, 2023.
Performance
EVH Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$154.05M-$32.81M(-17.56%)Summary
- As of today, EVH TTM cash from financing is $154.05 million, with the most recent change of -$32.81 million (-17.56%) on September 30, 2025.
- Over the past year, EVH TTM cash from financing has increased by +$335.91 million (+184.71%).
- EVH TTM cash from financing is now -72.75% below its all-time high of $565.29 million, reached on June 30, 2023.
Performance
EVH TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
EVH Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -100.2% | -364.2% | +184.7% |
| 3Y3 Years | +98.1% | -124.2% | -24.2% |
| 5Y5 Years | +98.4% | -201.8% | +10000.0% |
EVH Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -100.2% | +98.1% | -111.0% | +59.5% | -72.8% | +173.3% |
| 5Y | 5-Year | -100.2% | +98.4% | -111.0% | +59.5% | -72.8% | +173.3% |
| All-Time | All-Time | -100.2% | +98.4% | -111.0% | +61.7% | -72.8% | +173.3% |
EVH Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$41.81M(-368.4%) | $154.05M(-17.6%) |
| Jun 2025 | - | -$8.93M(-108.3%) | $186.86M(+102.2%) |
| Mar 2025 | - | $107.85M(+11.3%) | $92.41M(>+9900.0%) |
| Dec 2024 | -$565.00K(-100.2%) | $96.94M(+1176.2%) | -$565.00K(+99.7%) |
| Sep 2024 | - | -$9.01M(+91.3%) | -$181.86M(+13.5%) |
| Jun 2024 | - | -$103.38M(-794.7%) | -$210.22M(-151.7%) |
| Mar 2024 | - | $14.88M(+117.6%) | -$83.51M(-129.7%) |
| Dec 2023 | $281.34M(+113.9%) | -$84.35M(-125.7%) | $281.34M(-20.7%) |
| Sep 2023 | - | -$37.37M(-260.2%) | $354.84M(-37.2%) |
| Jun 2023 | - | $23.33M(-93.9%) | $565.29M(+0.5%) |
| Mar 2023 | - | $379.73M(+3598.5%) | $562.65M(+327.7%) |
| Dec 2022 | $131.54M(+545.2%) | -$10.85M(-106.3%) | $131.54M(-35.3%) |
| Sep 2022 | - | $173.08M(+736.5%) | $203.29M(+558.9%) |
| Jun 2022 | - | $20.69M(+140.3%) | $30.85M(+221.8%) |
| Mar 2022 | - | -$51.38M(-184.4%) | -$25.34M(+14.2%) |
| Dec 2021 | -$29.55M(-149.1%) | $60.90M(+9400.5%) | -$29.55M(+74.2%) |
| Sep 2021 | - | $641.00K(+101.8%) | -$114.36M(+11.3%) |
| Jun 2021 | - | -$35.50M(+36.1%) | -$128.86M(-28.8%) |
| Mar 2021 | - | -$55.58M(-132.4%) | -$100.02M(-743.2%) |
| Dec 2020 | -$11.86M(+66.6%) | -$23.92M(-72.6%) | -$11.86M(-6001.5%) |
| Sep 2020 | - | -$13.86M(-107.9%) | $201.00K(-99.8%) |
| Jun 2020 | - | -$6.66M(-120.5%) | $110.83M(+4.5%) |
| Mar 2020 | - | $32.57M(+374.8%) | $106.09M(+398.5%) |
| Dec 2019 | -$35.55M | -$11.85M(-112.2%) | -$35.55M(-113.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $96.77M(+948.4%) | $258.27M(+64.3%) |
| Jun 2019 | - | -$11.41M(+89.5%) | $157.23M(-15.7%) |
| Mar 2019 | - | -$109.06M(-138.7%) | $186.57M(-31.9%) |
| Dec 2018 | $274.02M(+65.5%) | $281.96M(+6703.3%) | $274.02M(+2393.5%) |
| Sep 2018 | - | -$4.27M(-123.8%) | -$11.95M(-106.6%) |
| Jun 2018 | - | $17.94M(+183.0%) | $181.50M(+19.0%) |
| Mar 2018 | - | -$21.61M(-438.4%) | $152.58M(-7.8%) |
| Dec 2017 | $165.56M(+35.5%) | -$4.01M(-102.1%) | $165.56M(-43.1%) |
| Sep 2017 | - | $189.18M(+1822.0%) | $290.83M(+183.1%) |
| Jun 2017 | - | -$10.99M(-27.4%) | $102.74M(-9.5%) |
| Mar 2017 | - | -$8.63M(-107.1%) | $113.49M(-7.1%) |
| Dec 2016 | $122.14M(-41.2%) | $121.27M(>+9900.0%) | $122.14M(>+9900.0%) |
| Sep 2016 | - | $1.08M(+572.9%) | -$422.00K(+70.9%) |
| Jun 2016 | - | -$229.00K(-1016.0%) | -$1.45M(-100.7%) |
| Mar 2016 | - | $25.00K(+101.9%) | $207.90M(+0.0%) |
| Dec 2015 | $207.88M(>+9900.0%) | -$1.30M(-2509.3%) | $207.88M(-0.6%) |
| Sep 2015 | - | $54.00K(-100.0%) | $209.18M(+0.0%) |
| Jun 2015 | - | $209.13M(>+9900.0%) | $209.13M(>+9900.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | $34.29M(+661.9%) | - | - |
| Dec 2012 | $4.50M | - | - |
FAQ
- What is Evolent Health, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Evolent Health, Inc.?
- What is Evolent Health, Inc. annual cash from financing year-on-year change?
- What is Evolent Health, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Evolent Health, Inc.?
- What is Evolent Health, Inc. quarterly cash from financing year-on-year change?
- What is Evolent Health, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Evolent Health, Inc.?
- What is Evolent Health, Inc. TTM cash from financing year-on-year change?
What is Evolent Health, Inc. annual cash from financing?
The current annual cash from financing of EVH is -$565.00K
What is the all-time high annual cash from financing for Evolent Health, Inc.?
Evolent Health, Inc. all-time high annual cash from financing is $281.34M
What is Evolent Health, Inc. annual cash from financing year-on-year change?
Over the past year, EVH annual cash from financing has changed by -$281.90M (-100.20%)
What is Evolent Health, Inc. quarterly cash from financing?
The current quarterly cash from financing of EVH is -$41.81M
What is the all-time high quarterly cash from financing for Evolent Health, Inc.?
Evolent Health, Inc. all-time high quarterly cash from financing is $379.73M
What is Evolent Health, Inc. quarterly cash from financing year-on-year change?
Over the past year, EVH quarterly cash from financing has changed by -$32.81M (-364.20%)
What is Evolent Health, Inc. TTM cash from financing?
The current TTM cash from financing of EVH is $154.05M
What is the all-time high TTM cash from financing for Evolent Health, Inc.?
Evolent Health, Inc. all-time high TTM cash from financing is $565.29M
What is Evolent Health, Inc. TTM cash from financing year-on-year change?
Over the past year, EVH TTM cash from financing has changed by +$335.91M (+184.71%)